- Home
- HRMY vs AMC Comparison
HRMY vs AMC Comparison
Compare HRMY & AMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- AMC
- Stock Information
- Founded
- HRMY 2017
- AMC 1920
- Country
- HRMY United States
- AMC United States
- Employees
- HRMY N/A
- AMC N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- AMC Movies/Entertainment
- Sector
- HRMY Health Care
- AMC Consumer Discretionary
- Exchange
- HRMY Nasdaq
- AMC Nasdaq
- Market Cap
- HRMY 1.8B
- AMC 1.3B
- IPO Year
- HRMY 2020
- AMC 2013
- Fundamental
- Price
- HRMY $34.71
- AMC $3.30
- Analyst Decision
- HRMY Strong Buy
- AMC Hold
- Analyst Count
- HRMY 9
- AMC 8
- Target Price
- HRMY $54.44
- AMC $3.93
- AVG Volume (30 Days)
- HRMY 604.5K
- AMC 10.2M
- Earning Date
- HRMY 08-05-2025
- AMC 08-01-2025
- Dividend Yield
- HRMY N/A
- AMC N/A
- EPS Growth
- HRMY 13.13
- AMC N/A
- EPS
- HRMY 2.62
- AMC N/A
- Revenue
- HRMY $744,852,000.00
- AMC $4,548,300,000.00
- Revenue This Year
- HRMY $20.33
- AMC $8.36
- Revenue Next Year
- HRMY $17.67
- AMC $6.63
- P/E Ratio
- HRMY $12.97
- AMC N/A
- Revenue Growth
- HRMY 20.62
- AMC N/A
- 52 Week Low
- HRMY $26.47
- AMC $2.45
- 52 Week High
- HRMY $41.61
- AMC $5.76
- Technical
- Relative Strength Index (RSI)
- HRMY 63.75
- AMC 61.64
- Support Level
- HRMY $33.76
- AMC $2.82
- Resistance Level
- HRMY $35.08
- AMC $2.96
- Average True Range (ATR)
- HRMY 0.91
- AMC 0.11
- MACD
- HRMY 0.32
- AMC 0.02
- Stochastic Oscillator
- HRMY 90.34
- AMC 93.86
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About AMC AMC Entertainment Holdings Inc.
AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.